Cryptococcosis in solid organ transplant recipients: current state of the science
- PMID: 18840080
- PMCID: PMC2696098
- DOI: 10.1086/592690
Cryptococcosis in solid organ transplant recipients: current state of the science
Abstract
Cryptococcosis remains a significant opportunistic infection in solid organ transplant recipients. Disease presentation and outcomes may be affected by, among other factors, the use of calcineurin inhibitor immunosuppressive agents. It is being increasingly recognized that rapid reversal of immunosuppression in transplant recipients treated for cryptococcosis incurs the risk of immune reconstitution inflammatory syndrome, which resembles worsening disease or relapse. This review summarizes the current state of knowledge regarding cryptococcosis in transplant recipients and highlights areas where future investigations are needed to further optimize outcomes for these patients.
References
-
- Paya CV. Fungal infections in solid-organ transplanation. Clin Infect Dis. 1993;16:677–688. - PubMed
-
- Kanj SS, Welty-Wolf K, Madden J, Tapson V, Baz MA, Davis D, Perfect JR. Fungal infections in lung and heart-lung transplant recipients: report of 9 cases and review of the literature. Medicine. 1996;75:142–156. - PubMed
-
- Fortun J, Martin-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, Garcia M, Nuno J, Candela A, Uriarte M, Pintado V. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemotherap. 2003;52:813–819. - PubMed
-
- Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation. 2001;71:910–913. - PubMed
